Detection of isolated tumor cells in neuroblastoma by immunohistochemical analysis in bone marrow biopsy specimens improved detection with use of ß-catenin

American Journal of Clinical Pathology

Volumn 131, Issue 1, 2009, Pages 49-57

  Krishnan, Chandra ^a   Twist, Clare J ^b   Fu, Teresa ^a   Arber, Daniel A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

Bone marrow; Immunohistochemistry; Metastasis; Minimal residual disease; Neuroblastoma

Indexed keywords

BETA CATENIN; CHROMOGRANIN; SYNAPTOPHYSIN;

ARTICLE; BONE MARROW BIOPSY; CANCER SURVIVAL; CELL ISOLATION; CHILD; CONTROLLED STUDY; EWING SARCOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SCHOOL CHILD; TUMOR CELL;

BETA CATENIN; BIOPSY; BONE MARROW; BONE MARROW EXAMINATION; CHILD; CHILD, PRESCHOOL; CHROMOGRANINS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; KAPLAN-MEIERS ESTIMATE; MALE; NEOPLASM METASTASIS; NEUROBLASTOMA; SYNAPTOPHYSIN;

EID: 58549109006     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPAJODRJYD3OB2     Document Type: Article

References (18)

1. Goodman MT, Gurney JG, Smith MA, et al. Sympathetic nervous system tumors (ICCC IV). In: National Cancer Institute 65 SEER Pediatric Monograph. 2007. National Cancer Institute Surveillance, Epidemiology and End Results Database. http://seer.cancer.gov/publications/childhood/sympathetic.pdf. Accessed November 2007.
2. Joshi VV. Peripheral neuroblastic tumors: pathologic classification based on recommendations of International Neuroblastoma Pathology Committee (modification of Shimada classification). Pediatr Dev Pathol. 2000;3:184-199.
3. Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma. Lancet. 2007;369:2106-2120.
4. Peuchmaur M, d'Amore ES, Joshi VV, et al. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer. 2003;98:2274-2281.
5. Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer. 1999;86:364-372.
6. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:1466-1477.
7. Thomas JO, Nijjar J, Turley H, et al. NB84: a new monoclonal antibody for the recognition of neuroblastoma in routinely processed material. J Pathol. 1991;163:69-75.
8. Wirnsberger GH, Becker H, Ziervogel K, et al. Diagnostic immunohistochemistry of neuroblastic tumors. Am J Surg Pathol. 1992;16:49-57.
9. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847.
10. Burchill SA. Micrometastases in neuroblastoma: are they clinically important? J Clin Pathol. 2004;57:14-20.
11. Moss TJ, Reynolds CP, Sather HN, et al. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med. 1991;324:219-226.
12. Miettinen M, Chatten J, Paetau A, et al. Monoclonal antibody NB84 in the differential diagnosis of neuroblastoma and other small round cell tumors. Am J Surg Pathol. 1998;22:327-332.
13. Beiske K, Ambros PF, Burchill SA, et al. Detecting minimal residual disease in neuroblastoma patients: the present state of the art. Cancer Lett. 2005;228:229-240.
14. Seeger RC, Reynolds CP, Gallego R, et al. Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study. J Clin Oncol. 2000;18:4067-4076.
15. Cheung NK, Heller G, Kushner BH, et al. Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive? J Clin Oncol. 1997;15:2807-2817.
16. Swerts K, De Moerloose B, Dhooge C, et al. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry. Cytometry B Clin Cytom. 2004;61:9-19.
17. Rogers DW, Treleaven JG, Kemshead JT, et al. Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma. J Clin Pathol. 1989;42:422-426.
18. Bomken SN, Redfern K, Wood KM, et al. Limitations in the ability of NB84 to detect metastatic neuroblastoma cells in bone marrow. J Clin Pathol. 2006;59:927-929.